Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 3/20 | 0.51 |
| ▸ | CACNA1H | O95180 | 9/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.40 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.39 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27800945 | 0.85 | CDK9 (0.69) | CDK9CACNA1HMEN1KMT2ARAB9A | |
| SCHEMBL27821928 | 0.83 | CDK9 (0.47) | CDK9CACNA1HMEN1KMT2ARAB9A | |
| SCHEMBL27821788 | 0.83 | CDK9 (0.51) | CDK9CACNA1HMEN1KMT2ARAB9A | |
| SCHEMBL28789685 | 0.83 | CDK9 (0.51) | CDK9CACNA1HMEN1KMT2ARAB9A | |
| SCHEMBL1849533 | 0.83 | CDK9 (0.74) | CDK9KMT2A | |
| SCHEMBL27821812 | 0.83 | MEN1 (0.56) | CDK9MEN1KMT2ARIOK2 | |
| SCHEMBL27801096 | 0.82 | CDK9 (0.71) | CDK9CACNA1HRIOK2 | |
| SCHEMBL27800912 | 0.81 | CDK9 (0.48) | CDK9MEN1KMT2AANO1AAK1 | |
| SCHEMBL27800967 | 0.80 | CDK9 (0.49) | CDK9MEN1KMT2ARAB9AANO1 | |
| SCHEMBL27822255 | 0.79 | CDK9 (0.46) | CDK9CACNA1HMEN1KMT2AANO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101889004-A | Protein kinase inhibitors | INGENIUM PHARMACEUTICALS GMBH | 2010-11-17 | — | — | CN | disclosed |